These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 24129123)

  • 1. Priorities for CMV vaccine development.
    Krause PR; Bialek SR; Boppana SB; Griffiths PD; Laughlin CA; Ljungman P; Mocarski ES; Pass RF; Read JS; Schleiss MR; Plotkin SA
    Vaccine; 2013 Dec; 32(1):4-10. PubMed ID: 24129123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunological underpinnings of vaccinations to prevent cytomegalovirus disease.
    McCormick AL; Mocarski ES
    Cell Mol Immunol; 2015 Mar; 12(2):170-9. PubMed ID: 25544503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.
    Liu Y; Freed DC; Li L; Tang A; Li F; Murray EM; Adler SP; McVoy MA; Rupp RE; Barrett D; Ye X; Zhang N; Beck K; Culp T; Das R; Song L; Vora K; Zhu H; Wang D; Espeseth AS; An Z; Musey L; Fu TM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modestly protective cytomegalovirus vaccination of young children effectively prevents congenital infection at the population level.
    Byrne C; Coombs D; Gantt S
    Vaccine; 2022 Aug; 40(35):5179-5188. PubMed ID: 35907677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus (CMV) seroprevalence among women at childbearing age, maternal and congenital CMV infection: policy implications of a descriptive, retrospective, community-based study.
    Ben Shoham A; Schlesinger Y; Miskin I; Kalderon Z; Michaelson-Cohen R; Wiener-Well Y
    Isr J Health Policy Res; 2023 Apr; 12(1):16. PubMed ID: 37098565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections.
    Permar SR; Schleiss MR; Plotkin SA
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and long-term impact of vaccination against cytomegalovirus: a modeling study.
    Rozhnova G; E Kretzschmar M; van der Klis F; van Baarle D; Korndewal M; C Vossen A; van Boven M
    BMC Med; 2020 Jul; 18(1):174. PubMed ID: 32611419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine value profile for cytomegalovirus.
    Boppana SB; van Boven M; Britt WJ; Gantt S; Griffiths PD; Grosse SD; Hyde TB; Lanzieri TM; Mussi-Pinhata MM; Pallas SE; Pinninti SG; Rawlinson WD; Ross SA; Vossen ACTM; Fowler KB
    Vaccine; 2023 Nov; 41 Suppl 2():S53-S75. PubMed ID: 37806805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion of the Viral Pentamer Complex in a Vaccine Design Greatly Improves Protection against Congenital Cytomegalovirus in the Guinea Pig Model.
    Choi KY; El-Hamdi NS; McGregor A
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31484753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of Mathematical Models of Vaccination for Preventing Congenital Cytomegalovirus Infection.
    Lanzieri TM; Gastañaduy PA; Gambhir M; Plotkin SA
    J Infect Dis; 2020 Mar; 221(Suppl 1):S86-S93. PubMed ID: 32134475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural History of Congenital Cytomegalovirus Infection in Highly Seropositive Populations.
    Mussi-Pinhata MM; Yamamoto AY
    J Infect Dis; 2020 Mar; 221(Suppl 1):S15-S22. PubMed ID: 32134482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convalescent Immunity to Guinea Pig Cytomegalovirus Induces Limited Cross Strain Protection against Re-Infection but High-Level Protection against Congenital Disease.
    Choi KY; El-Hamdi NS; McGregor A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of cytomegalovirus vaccines: prospects for prevention of congenital CMV infection.
    Pass RF; Burke RL
    Semin Pediatr Infect Dis; 2002 Jul; 13(3):196-204. PubMed ID: 12199616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Current Challenges in Developing Biological and Clinical Predictors of Congenital Cytomegalovirus Infection.
    Tanimura K; Uchida A; Imafuku H; Tairaku S; Fujioka K; Morioka I; Yamada H
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of pre-existing natural immunity in a nonhuman primate reinfection model of congenital cytomegalovirus infection.
    Moström M; Yu S; Tran D; Saccoccio F; Versoza CJ; Malouli D; Mirza A; Valencia S; Gilbert M; Blair R; Hansen S; Barry P; Früh K; Jensen JD; Pfeifer SP; Kowalik TF; Permar SR; Kaur A
    bioRxiv; 2023 Apr; ():. PubMed ID: 37090643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine Development for Cytomegalovirus.
    Inoue N; Abe M; Kobayashi R; Yamada S
    Adv Exp Med Biol; 2018; 1045():271-296. PubMed ID: 29896672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial.
    Aldoss I; La Rosa C; Baden LR; Longmate J; Ariza-Heredia EJ; Rida WN; Lingaraju CR; Zhou Q; Martinez J; Kaltcheva T; Dagis A; Hardwick N; Issa NC; Farol L; Nademanee A; Al Malki MM; Forman S; Nakamura R; Diamond DJ;
    Ann Intern Med; 2020 Mar; 172(5):306-316. PubMed ID: 32040960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Kharfan-Dabaja MA; Boeckh M; Wilck MB; Langston AA; Chu AH; Wloch MK; Guterwill DF; Smith LR; Rolland AP; Kenney RT
    Lancet Infect Dis; 2012 Apr; 12(4):290-9. PubMed ID: 22237175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a cytomegalovirus vaccine: lessons from recent clinical trials.
    Gonczol E; Plotkin S
    Expert Opin Biol Ther; 2001 May; 1(3):401-12. PubMed ID: 11727514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of maternal cytomegalovirus-specific antibody responses and viral load to vertical transmission risk following primary maternal infection in a rhesus macaque model.
    Otero CE; Barfield R; Scheef E; Nelson CS; Rodgers N; Wang HY; Moström MJ; Manuel TD; Sass J; Schmidt K; Taher H; Papen C; Sprehe L; Kendall S; Davalos A; Barry PA; Früh K; Pollara J; Malouli D; Chan C; Kaur A; Permar SR
    PLoS Pathog; 2023 Oct; 19(10):e1011378. PubMed ID: 37871009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.